Dataset Information

Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency.

ABSTRACT: Ex vivo gene therapy using lentiviral vectors (LVs) is a proven approach to treat and potentially cure many hematologic disorders and malignancies but remains stymied by cumbersome, cost-prohibitive, and scale-limited production processes that cannot meet the demands of current clinical protocols for widespread clinical utilization. However, limitations in LV manufacture coupled with inefficient transduction protocols requiring significant excess amounts of vector currently limit widespread implementation. Herein, we describe a microfluidic, mass transport-based approach that overcomes the diffusion limitations of current transduction platforms to enhance LV gene transfer kinetics and efficiency. This novel ex vivo LV transduction platform is flexible in design, easy to use, scalable, and compatible with standard cell transduction reagents and LV preparations. Using hematopoietic cell lines, primary human T cells, primary hematopoietic stem and progenitor cells (HSPCs) of both murine (Sca-1+) and human (CD34+) origin, microfluidic transduction using clinically processed LVs occurs up to 5-fold faster and requires as little as one-twentieth of LV. As an in vivo validation of the microfluidic-based transduction technology, HSPC gene therapy was performed in hemophilia A mice using limiting amounts of LV. Compared to the standard static well-based transduction protocols, only animals transplanted with microfluidic-transduced cells displayed clotting levels restored to normal.

SUBMITTER: Tran R

PROVIDER: S-EPMC5628863 | biostudies-other | 2017 Oct

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency.

Tran Reginald R Myers David R DR Denning Gabriela G Shields Jordan E JE Lytle Allison M AM Alrowais Hommood H Qiu Yongzhi Y Sakurai Yumiko Y Li William C WC Brand Oliver O Le Doux Joseph M JM Spencer H Trent HT Doering Christopher B CB Lam Wilbur A WA

Molecular therapy : the journal of the American Society of Gene Therapy 20170708 10

Ex vivo gene therapy using lentiviral vectors (LVs) is a proven approach to treat and potentially cure many hematologic disorders and malignancies but remains stymied by cumbersome, cost-prohibitive, and scale-limited production processes that cannot meet the demands of current clinical protocols for widespread clinical utilization. However, limitations in LV manufacture coupled with inefficient transduction protocols requiring significant excess amounts of vector currently limit widespread impl ...[more]

PMID: 28780274

Similar Datasets

Project description:In photovoltaic devices, more effective transfer of dissociated electrons and holes from the active layer to the respective electrodes will result in higher fill factors and short-circuit current densities and, thus, enhanced power conversion efficiencies (PCEs). Planar perovskite photovoltaics feature an active layer that can provide a large exciton diffusion length, reaching several micrometers, but require efficient carrier transport layers for charge extraction. In this study, we employed two nanocomposite carrier transfer layers-an electron transport layer (ETL) comprising [6,6]phenyl-C61-butyric acid methyl ester (PC61BM) doped with the small molecule 4,7-diphenyl-1,10-phenanthroline (Bphen), to enhance the electron mobility, and a hole transfer layer (HTL) comprising poly(3,4-ethylenedioxythiophene):polystyrenesulfonate (PEDOT:PSS) doped with molybdenum disulfide (MoS2) nanosheets, to enhance the hole mobility. We used ultraviolet photoelectron spectroscopy to determine the energy levels of these composite ETLs and HTLs; atomic force microscopy and scanning electron microscopy to probe their surface structures; and transmission electron microscopy and synchrotron grazing-incidence small-angle X-ray scattering to decipher the structures of the ETLs. Adding a small amount (less than 1%) of Bphen allowed us to tune the energy levels of the ETL and decrease the size of the PC61BM clusters and, therefore, generate more PC61BM aggregation domains to provide more pathways for electron transport, leading to enhanced PCEs of the resulting perovskite devices. We used quantitative pump-probe data to resolve the carrier dynamics from the perovskite to the ETL and HTL, and observed a smaller possibility of carrier recombination and a shorter injection lifetime in the perovskite solar cell doubly modified with carrier transport layers, resulting in an enhancement of the PCE. The PCE reached 16% for a planar inverted perovskite device featuring an ETL incorporating 0.5 wt% Bphen within PC61BM and 0.1 wt% MoS2 within PEDOT:PSS; this PCE is more than 50% higher than the value of 10.2% for the corresponding control device.

Project description:Initial conditions (pre-equilibrium or after the first flooding of the column), mass transfer mechanisms and sample composition (heterogeneity) have a strong impact on leaching of less and strongly sorbing compounds in column percolation tests. Mechanistic models as used in this study provide the necessary insight to understand the complexity of column leaching tests especially when heterogeneous samples are concerned. By means of numerical experiments, we illustrate the initial concentration distribution inside the column after the first flooding and how this impacts leaching concentrations. Steep concentration gradients close to the outlet of the column have to be expected for small distribution coefficients (Kd<1 L kg-1) and longitudinal dispersion leads to smaller initial concentrations than expected under equilibrium conditions. In order to elucidate the impact of different mass transfer mechanisms, film diffusion across an external aqueous boundary layer (first order kinetics, FD) and intraparticle pore diffusion (IPD) are considered. The results show that IPD results in slow desorption kinetics due to retarded transport within the tortuous intragranular pores. Non-linear sorption has not much of an effect if compared to Kd values calculated for the appropriate concentration range (e.g., the initial equilibrium concentration). Sample heterogeneity in terms of grain size and different fractions of sorptive particles in the sample have a strong impact on leaching curves. A small fraction (<1%) of strongly sorbing particles (high Kd) carrying the contaminant may lead to very slow desorption rates (because of less surface area)-especially if mass release is limited by IPD-and thus non-equilibrium. In contrast, mixtures of less sorbing fine material ("labile" contamination with low Kd), with a small fraction of coarse particles carrying the contaminant leads to leaching close to or at equilibrium showing a step-wise concentration decline in the column effluent.

Project description:In this study, we developed a new purification method using chondroitin sulfate C (CSC) and protamine sulfate (PS) to concentrate lentivirus. To evaluate the efficiency of this new method, we compared it with several previously described purification protocols, including virus concentrated by ultracentrifugation (Ultra), precipitated by polyethylene glycol (PEG), and sedimented by CSC combined with polybrene (PB). After using the different methods to purify and concentrate equivalent amounts of lentivirus supernatant, the virus pellets precipitated by the different methods were resuspended using the equivalent volumes of DMEM. Subsequently, 10 ?l of each lentivirus stock carrying EGFP gene was used to transduce two types of cells, human embryonic kidney 293T (HEK293T) cells and mouse mesenchymal stem cells (mMSC). It was obvious that HEK293T and mMSC appeared much intensiver green fluorescence through virus transduction from PS method than from other methods. To quantitate the transduction efficiency of the viruses, we examined virus titer in the cells after transduction using a real-time PCR-based analysis. Accordingly, we verified that PS precipitation could generate virus with a higher titer (4.39 × 108 IU/ml) than PB (2.43 × 108 IU/ml), Ultra (1.16 × 108 IU/ml), and PEG (0.56 × 108 IU/ml) in HEK293T cells. As for HEK293T cells in mMSC, the PS method also generated virus with a higher titer (4.66 × 108 IU/ml) than the Ultra method (2.36 × 108 IU/ml), and a much higher titer than those of the other chemical-based precipitation methods using PB (4.82 × 106 IU/ml) and PEG (8.98 × 104 IU/ml). Furthermore, the HEK293T cells and mMSC transduced by PS(1X)-virus appeared to have higher cell growth ratios, respectively, than the HEK293T cells and mMSC transduced by lentivirus using the other methods. We conclude that our new method for purifying lentivirus is cost-effective, time-saving, and highly efficient, and that lentivirus purification by this means could possibly be used to transduce a variety of cells, including stem cells.

Dataset Information

Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency.

Publications

Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets